Ampio Pharmaceuticals (NYSE:AMPE) Now Covered by Analysts at StockNews.com

StockNews.com began coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a report released on Monday. The firm set a “sell” rating on the stock.

Ampio Pharmaceuticals Price Performance

Ampio Pharmaceuticals stock opened at $0.00 on Monday. Ampio Pharmaceuticals has a 12 month low of $0.00 and a 12 month high of $1.05. The stock has a market capitalization of $681.00, a price-to-earnings ratio of 0.00 and a beta of 3.77.

Ampio Pharmaceuticals Company Profile

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.